# HG-P02: [HUMAN-GATE] Decision Draft

- **Status:** PROPOSED (awaiting human decision)
- **Date:** 2026-08-27
- **affects-phases:** P02
- **affects-ledger-rows:** CLM-001, CLM-002, CLM-003, CLM-004, CLM-005

---

## Context and Problem Statement
Phase 02 Hypothesis Formulation, Mathematical Reduction & Risk Scoring complete. Continuous gradient flow in two-subspace reduction formally derives transverse eigenvalue mu_perp = lambda a_C - b_C and critical threshold lambda_crit = b_C / a_C (ADR-001). Scientific hypotheses (H_0, H_null, H_alt) and 3 observable signatures operationalized (ADR-003). Continuous ODE solver (two_subspace_ode.py, observable_signatures.py) and figures generated. Risk #1 (Separatrix vs Smooth Sigmoid) designated as the Phase 03 Gate target. Pending PI approval.

## Considered Options
  1. **Approve Central Hypothesis H_0, Analytical Reduction (ADR-001), and Designation of Risk #1 as Phase 03 Gate Target, and proceed to Pre-Registration (P02.5).** — trade-offs: Locks in the two-subspace continuous gradient flow model and binds the existence of a sharp separatrix P(escape | lambda) as the strict empirical gate target for P03.
  2. **Require modification of analytical assumptions (e.g. non-orthogonal subspace couplings or higher-order curvature terms) before pre-registration.** — trade-offs: Enriches the theoretical model with additional coupling degrees of freedom, but increases analytical complexity without altering the fundamental transverse stability exchange mu_perp = lambda a_C - b_C.
  3. **Reject transcritical bifurcation mechanism in favor of smooth dose-response (H_null) or scale-only emergence (H_alt).** — trade-offs: Abandons the dynamical-systems threshold derivation and pivots Paper 02 back to empirical curve fitting or scale-only benchmarking.

## Decision Outcome
**Chosen Option:** *(BLANK — for human)*

### Positive Consequences
- *(BLANK — for human)*

### Negative Consequences / Risks
- *(BLANK — for human)*

## Human Gate Sign-off
- **Gate ID:** [HUMAN-GATE]
- **Approver:** *(BLANK — for human)*
- **Timestamp:** *(BLANK — for human)*
- **Verdict:** [ APPROVED / MODIFIED / REJECTED ] — *(BLANK — for human)*

*Drafted from `decisions/ADR-TEMPLATE.md`. Agent halts until the human records a decision.*
